Charlotte’s Web to Sponsor ValidCare CBD Clinical Trial

Charlotte’s Web Steps up to Support Research to Address FDA’s Request for More Scientific Data

ValidCare to Conduct Industry Leading Study on CBD and Human Health

BOULDER, Colo., June 9, 2020 /PRNewswire/ – (TSX: CWEB) (OTCQX: CWBHF) Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), the company behind the world’s most trusted hemp extract™ and the CBD industry market leader, announced its sponsorship, with six other CBD brands, of ValidCare’s scientific study, to address the Food and Drug Administration’s (FDA) prior public questions about CBD products.  ValidCare will be conducting a human trial study to ascertain if daily use of full spectrum hemp-derived CBD or CBD isolate has any impact on the human liver. In its report to Congress dated March 5, 2020, the FDA requested additional science-based data from the CBD industry. The ValidCare study will provide third-party scientific data intended to directly address some of the FDA specific requests.

As the market share leader, anchored in science, sponsoring ValidCare’s study made strategic sense for us. This research will provide important clinical data to guide our entire industry while also showing the FDA we’ve heard their requests and are answering their questions with precise data.

Deanie Elsner, Chief Executive Officer for Charlotte’s Web

Charlotte’s Web is one of only seven companies that agreed to participate in and fund this important research, out of more than 100 that were invited to take part.

“This is a particularly important time for research on the science behind hemp-derived CBD as we advocate for FDA regulation of our category,” said Tim Orr, Vice President of Innovation for Charlotte’s Web. “Charlotte’s Web invests in scientific research, including internal and external independent studies such as ValidCare’s. Prioritizing the science is essential to ensuring product safety, effectiveness and consumer trust.”

About ValidCare

ValidCare, LLC provides clinical research outsourcing (CRO) and consumer intelligence solutions for the hemp and healthcare industries.  ValidCare’s proprietary platform supports virtual research powered by real world evidence (RWE) including self-reported consumer data to deliver insights that help improve research, regulations, product development and consumer health. For more information, visit www.validcare.com or call 844-825-4322.

About Charlotte’s Web Holdings, Inc.

Founded by the seven Stanley Brothers in Colorado to unleash the healing power of botanicals through care, compassion and science, Charlotte’s Web Holdings, Inc. is the market leader in the growing, production and distribution of innovative hemp-derived cannabidiol (“CBD”) wellness products. The Company’s exceptional quality products, tested more than 20 times, start with proprietary hemp-derived CBD extracts naturally containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other beneficial hemp compounds. Industrial hemp products are non-intoxicating. Charlotte’s Web product categories include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, as well as CBD pet products. Charlotte’s Web hemp-derived products are sold in more than 11,000 brick and mortar stores, and online at www.CharlottesWeb.com. The rate the Company pays for agricultural products reflects a fair and sustainable rate driving higher quality yield, encouraging regenerative farming practices, and supporting U.S. farming communities.

Charlotte’s Web is a socially conscious company and is committed to using business as a force for good and a catalyst for innovation. The Company weighs sound business decisions with consideration for how its efforts affect its employees, customers, the environment, and the communities where its employees live and where it does business, while maximizing profits and strengthening its brands. The Company’s management believes that socially- and environmentally-conscious actions have a positive impact on the Company, its employees, its shareholders and society. Charlotte’s Web donates a portion of its pre-tax earnings to charitable organizations.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”. As of May 13, 2020, Charlotte’s Web had 71,945,914 Common Shares outstanding and 92,455.575 Proportional Voting Shares convertible at 400:1 into Common Shares, for an effective equivalent of 108,928,144 Common Shares outstanding.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter